Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
BL-M07D1 for HER2-Positive Cancer
Recruiting1 awardPhase 1
New York, New York
"This trial aims to test the safety, side effects, and effectiveness of BL-M07D1 in patients with advanced tumors that have a specific protein called HER2."
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service